Finance

Lists
600216:SHA
Zhejiang Medicine Co Ltd
CNÂ¥11.17
+1.82%
(+0.20) 1D
Nov 4, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600216...
Open
CNÂ¥11.03
High
CNÂ¥11.29
Low
CNÂ¥10.94
Mkt. cap
10.55B
Avg. vol.
12.56M
Volume
19.93M
Dividend
2.51%
Quarterly dividend
CNÂ¥0.07
Ex-dividend date
Jul 9, 2026
P/E ratio
17.02
52-wk high
CNÂ¥18.58
52-wk low
CNÂ¥10.49
EPS
CNÂ¥0.66
Shares outstanding
965.26M
No. of employees
5K
Open
CNÂ¥11.03
High
CNÂ¥11.29
Low
CNÂ¥10.94
Mkt. cap
10.55B
Avg. vol.
12.56M
Volume
19.93M
Dividend
2.51%
Quarterly dividend
CNÂ¥0.07
Ex-dividend date
Jul 9, 2026
P/E ratio
17.02
52-wk high
CNÂ¥18.58
52-wk low
CNÂ¥10.49
EPS
CNÂ¥0.66
Shares outstanding
965.26M
No. of employees
5K
News stories
From web sources and news partners
About Zhejiang Medicine Co Ltd
CEO-
Employees5.42K
FoundedMay 16, 1997
Headquarters-
SectorPharmaceutical industry
Industry-
Websitezmc.top
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
2.19B
2.19B
2.20B
1.86B
Cost of goods sold
1.80B
1.42B
1.36B
1.26B
Cost of revenue
1.80B
1.42B
1.36B
1.26B
Research and development expenses
106.60M
93.81M
152.64M
138.14M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
401.70M
336.15M
363.22M
313.31M
Operating expense
548.81M
437.74M
530.96M
444.78M
Total operating expenses
2.35B
1.86B
1.89B
1.70B
Operating income
-163.00M
330.27M
301.46M
156.28M
Other non operating income
-93.78M
-41.66M
40.12M
-105.09M
EBT including unusual items
-94.58M
306.45M
313.26M
46.30M
EBT excluding unusual items
-181.96M
304.24M
287.43M
147.82M
Income tax expense
11.92M
48.09M
56.06M
11.31M
Effective tax rate
-12.60%
15.69%
17.89%
24.42%
Other operating expenses
37.06M
4.17M
16.50M
-4.47M
Net income
-59.77M
287.01M
319.00M
86.78M
Net profit margin
-2.73%
13.10%
14.53%
4.67%
Earnings per share
-
-
-
-
Interest and investment income
6.19M
20.45M
29.71M
19.26M
Interest expense
-6.35M
-4.82M
-6.48M
-
Net interest expenses
-157.28K
15.62M
23.23M
19.26M
Depreciation and amortization charges
-
-
-
-
EBITDA
14.46M
507.74M
477.07M
333.74M
Gain or loss from assets sale
81.15K
-
-18.70K
18.70K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps